Abstract
HIV life (replication) cycle involves attachment and fusion of the HIV particle with host target cells to initiate the infectious cycle. Entry into the host cell results in conversion of the viral genes from an RNA form to a DNA form and integration of the viral genetic material into the chromosomes of the now infected cell, where it persists for the life of the host cell, resulting in replication and budding forming new virions that are released from the infected host cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955–1958
Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220:868–871
Benkirane M, Jin DY, Chun RF, et al. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by CCR5 delta 32. J Biol Chem 1997, 272:30603–30606
Berger E, Doms R, Fenyö E, et al. A new classification for HIV-1. Nature 1998, 391:240
Bozzette S, McCutchan J, Spector S, Wright B, Richman D. A cross-sectional comparison of persons with syncytium-and non-syncytium-inducing HIV. J Infect Dis 1993, 168:1374–1379
Brenchley J, Schacker T, Ruff L, et al. CD4R T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004, 200:749–759
Carr CM, Kim PS. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 1993, 73:823–832
Chan D, Kim P. HIV entry and its inhibition. Cell 1998, 93:681–684
Chan DC, Fass D, Berger JM, et al. Core structure of gp41 from the HIVenvelope glycoprotein Cell 1997, 89:263–273
Connor R, Sheridan K, Ceradini D, Choe S, Landay N. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997;185:621–628
Cormier EG, Dragic T. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J Virol 2002, 76:8953–8957
de Roda Husman AM, Blaak H, Brouwer M, et al. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection. J Immunol 1999, 163:4597–4603
Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996, 273:1856–1862
Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661–666
Douek D. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev 2003, 21:172–177
Dragic T, Litwin V, Allaway G, et al. HIV-1 entry into CD4R cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667–673
Dragic T, Trkola A, Lin SW, et al. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J Virol 1998, 72:279–285
Dragic T. An overview of the determinants of CCR5 and CXCR4 co-receptor function. J Gen Virol 2001, 82:1807–1814
Edwards T, McManus C, Richardson T, et al. Multimeric CD4+ and coreceptor binding is required to activate HIV-1 envelope protein trimers. Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections; February 4–8, 2001; Chicago, Illinois. Abstract 105
Fass D, Harrison SC, Kim PS. Nat Struct Biol 1996, 3:465–469
Feng Y, Broder C, Kennedy P, Berger E. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane. G protein-coupled receptor. Science 1996, 272:872–877
Frank I, Pope M. The enigma of dendritic cell-HIV interplay. Curr Mol Med 2002, 2:229–248
Furuta RA, Wild CT, Weng Y, et al. Capture of an early fusion-active conformation of HIV-1 gp41. Nat Struct Biol 1998, 5:276–279
Gallaher WR, Ball JM, Garry RF, et al. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res Hum Retrovir 1989, 5:431–440
Gallaher WR. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 1987, 50:327–328
Gupta P, Collins K, Ratner D, et al. Memory CD4R T cells are the earliest detectable HIV-1-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J Virol 2002, 76:9868–9876
Harrison SC. Mechanism of membrane fusion by viral envelope proteins. Adv Virus Res 2005, 64:231–261.
Hart TK, Kirsh R, Ellens H, et al. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc Natl Acad Sci USA 1991, 88:2189–2193
Hartley O, Klasse PJ, Sattentau QJ, et al. V3: HIV’s switch-hitter. AIDS Res Hum Retrovir 2005, 21:171–189
Huang Y, Paxton W, Wolinsky S et al. The role of a mutant CCR5 allele in HIVtransmission and disease progression. Nat Med 1996, 2:1240–1243
Jenkis M, Khoruts A, Ingulli E, et al. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001, 19:23–45
Kawamura T, Kurtz S, Blauvelt A, Shimada S. The role of Langerhans cells in the sexual transmission of HIV. J Dermatol Sci 2005;40:147–155
Klatzmann D, Champagne E, Chamaret S, et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984, 312:767–768
Koot M, Keet I, Vos A, de Goede R, Roos M, Coutinho R. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4R cell depletion and progression to AIDS. Ann Intern Med 1993, 118:681–688
Kowalski M, Potz J, Basiripour L, et al. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 1987;237:1351–1355
Kwong PD, Wyatt R, Robinson J, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393:648–659
Lederman M, Veazey R, Oxfford R, et al. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 2004, 306:485–487
Lee B, Leslie G, Soilleux E, et al. Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol 2001, 75:12028–12038
Liu R, Paxton W, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some mutiplyexposed individuals to HIV-1 infection Cell 1996, 86:367–377
Marmor M, Sheppard HW, Donnell D, et al. Homozygous and heterozygous CCR5-Delta32genotypes are associated with resistance to HIV infection. J Acquir Immune Defic Syndr 2001, 27:472–481
Mehandru S, Poles M, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4R T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004, 200:761–770
Moore J, Kitchen S, Pugach P, Zack J. The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of HIV type 1 infection. AIDS Res Hum Retroviruses 2004, 20:111–126
Moore JP, McKeating JA, Weiss RA, et al. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 1990, 250:1139–1142
Moyle GJ, Wildfire A, Mandalia S, et al. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection. J Inf Dis 2005, 191:866–872
Murphy P, Baggiolini M, Charo I, et al. International union of pharmacology. XXII Nomenclature for chemokine receptors. Pharmacol Rev 2000, 52:145–176
Myszka DG, Sweet RW, Hensley P, et al. Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci USA 2000, 97:9026–9031
Pope M, Betjes M, Romani N, et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994, 78:389–398
Pope M, Gezelter S, Gallo N, Hoffman L, Steinman R. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4R T cells. J Exp Med 1995, 182:2045–2056
Pope M, Haase A. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 2003, 9:847–852
Popovic M, Sarin PS, Robert-Gurroff M, et al. Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science 1983;219:856–859
Rizzuto CD, Wyatt R, Hernandez-Ramos N, et al. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998, 280:1949–1953
Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene Nature 1996, 382:722–725
Sattentau QJ, Clapham PR, Weiss RA, et al. The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS 1988, 2:101–105
Sattentau QJ, Moore JP. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991, 174:407–415
Schuitemaker H, Koot M, Kootstra N, et al. Biological phenotype of HIV type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992, 66:1354–1360
Spijderman I, de Wolf F, Langendam M, Schuitemaker H, Coutinho R. Emergence of syncytium-inducing HIV type 1 variants coincides with a progression to AIDS. J Infect Dis 1998, 178:397–403
Spira A, Marx P, Patterson B, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996, 183:215–225
Tersmette M, de Goede R, Al B, et al. Differential syncytium-inducing capacity of HIV isolates: frequent detection of syncytium-inducing isolates in patients with AIDS and AIDS-related complex. J Virol 1988, 62:2026–2032
Veaze R, DeMaria M, Chalifoux L, et al. Gastrointestinal tract as a major site of CD4R T cell depletion and viral replication in SIV infection. Science 1998, 280:427–431
Weiss RA, Clapham PR, McClure MO, et al. Human immunodeficiency viruses: neutralization and receptors. J Acquir Immune Defic Syndr 1988, 1:536–541
Weissenhorn W, Dessen A, Harrison SC, et al. Atomic structure of the ectodomain from HIV-1 gp41. Nature 1997, 387:426–430
Weissenhorn W, Carfi A, Lee KH, et al. Mol Cell 1998, 2:605–616
Wessenhorn W, Calder LJ, Dessen A, Laue T, Skehel JJ, Wiley DC. Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV gp41 ectodomain expressed in Escherichia coli. Proc Natl Acad Sci USA 1997, 94:6065–6069
Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1, in vitro. J Exp Med 1997, 185:1681–1691
Wu L, Paxton WA, Kassam N, et al. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med 1997, 186:1373–1381
Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens». Science 1998, 280:1884–1888
Yachou A, Sekaly RP. Binding of soluble recombinant HIV envelope glycoprotein, rgp120, induces conformational changes in the cellular membrane-anchored CD4 molecule. Biochem Biophys Res Commun 1999, 265:428–433
Zhang L, He T, Talal A, Wang G, Frankel S, Ho D. In vivo distribution of the HIV/simian immunodeficiency virus coreceptors: CXCR4, CCR5, and CCR5. J Virol 1998, 72:5035–5045
Zhang Z, Schuler T, Zupancic M, et al. Sexual transmission and propagation of simian and HIV in two distinguishable populations of CD4R T cells. Science 1999, 286:1353–1357
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Panos, G., Nelson, M. (2008). Viral (HIV) Entry: How Does It Work?. In: Jäger, H. (eds) Entry Inhibitoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78358-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-540-78358-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78357-2
Online ISBN: 978-3-540-78358-9
eBook Packages: Medicine (German Language)